Astrocyte‐specific insulin‐like growth factor‐1 gene transfer in aging female rats improves stroke outcomes
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Middle aged female rats sustain larger stroke infarction and disability than younger female rats. This older group also shows age‐related reduction of insulin like growth factor (IGF)−1 in serum and in astrocytes, a cell type necessary for poststroke recovery. To determine the impact of astrocytic IGF‐1 for ischemic stroke, these studies tested the hypothesis that gene transfer of IGF‐1 to astrocytes will improve stroke outcomes in middle aged female rats. Middle aged (10‐12 month old), acyclic female rats were injected with recombinant adeno‐associated virus serotype 5 (AAV5) packaged with the coding sequence of the human (h)IGF‐1 gene downstream of an astrocyte‐specific promoter glial fibrillary acidic protein (GFAP) (AAV5‐GFP‐hIGF‐1) into the striatum and cortex. The AAV5‐control consisted of an identical shuttle vector construct without the hIGF‐1 gene (AAV5‐GFAP‐control). Six to eight weeks later, animals underwent transient (90 min) middle cerebral artery occlusion via intraluminal suture. While infarct volume was not altered, AAV5‐GFAP‐hIGF‐1 treatment significantly improved blood pressure and neurological score in the early acute phase of stroke (2 days) and sensory‐motor performance at both the early and late (5 days) acute phase of stroke. AAV5‐GFAP‐hIGF‐1 treatment also reduced circulating serum levels of GFAP, a biomarker for blood brain barrier permeability. Flow cytometry analysis of immune cells in the brain at 24 hr poststroke showed that AAV5‐GFAP‐hIGF‐1 altered the type of immune cells trafficked to the ischemic hemisphere, promoting an anti‐inflammatory profile. Collectively, these studies show that targeted enhancement of IGF‐1 in astrocytes of middle‐aged females improves stroke‐induced behavioral impairment and neuroinflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transfer of mitochondria from astrocytes to neurons after stroke
Hayakawa, K., Esposito, E., Wang, X., Terasaki, Y., Liu, Y., Xing, C., Ji, X., & Lo, E. H. (2016) · Nature · doi:10.1038/nature18928 · Cited by 1,423 · cited 3×
“(Hayakawa et al., 2016).”
BackgroundAstrocyte Senescence as a Component of Alzheimer’s Disease
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045069 · Cited by 586 · cited 2×
“Similarly, while astrocytes normally release a variety of trophic factors that promote neuronal survival and curb CNS degeneration (Ridet, Malhotra, Privat, & Gage, 1997) including insulin like growth factor (IGF)21 and VEGF (Chisholm & Sohrabji, 2016), these secretions decrease with age (Bhat et al., 2012; Lewis et a…”
BackgroundSalminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07738.x · Cited by 333
Olsen, M. L., & Sontheimer, H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05615.x · Cited by 323 · cited 1×
“They provide growth factors (Karki, Smith, Johnson, & Lee, 2014), clear glutamate (Olsen & Sontheimer, 2008), preserve blood brain barrier function (Abbott, Ronnback, & Hansson, 2006) (Cekanaviciute & Buckwalter, 2016), interact with the immune system (Xie & Yang, 2015), combat oxidative stress (Xu…”
BackgroundTargeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease
Furman, J. L., Sama, D. M., Gant, J. C., Beckett, T. L., Murphy, M. P., Bachstetter, A. D., Van Eldik, L. J., & Norris, C. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2323-12.2012 · Cited by 313
A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke
Overman, J. J., Clarkson, A. N., Wanner, I. B., Overman, W. T., Eckstein, I., Maguire, J. L., Dinov, I. D., Toga, A. W., & Carmichael, S. T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204386109 · Cited by 245 · cited 1×
“Additionally, blocking ephrin-A5 signaling, an important pathway for axonal sprouting in premotor and prefrontal motor circuits, in reactive astrocytes after MCAo also improved motor function recovery without a significant change in infarct volume (Overman et al., 2012).”
BackgroundAstrocytes: Integrative Regulators of Neuroinflammation in Stroke and Other Neurological Diseases
Cekanaviciute, E., & Buckwalter, M. S. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0477-8 · Cited by 229 · cited 1×
“…Smith, Johnson, & Lee, 2014), clear glutamate (Olsen & Sontheimer, 2008), preserve blood brain barrier function (Abbott, Ronnback, & Hansson, 2006) (Cekanaviciute & Buckwalter, 2016), interact with the immune system (Xie & Yang, 2015), combat oxidative stress (Xu et al., 2010) and produce…”
BackgroundAstrocytic contributions to bioenergetics of cerebral ischemia
Dienel, G. A., & Hertz, L. (2005) · Glia · doi:10.1002/glia.20157 · Cited by 150 · cited 1×
“Astrocytes are less vulnerable to ischemic injury than neurons (Dienel & Hertz, 2005)and have a greater capacity for selfpreservation (Allaman, Belanger, & Magistretti, 2011), indicating that these cells may play a crucial role in poststroke recovery.”
BackgroundKarki, P., Smith, K., Johnson, J., & Lee, E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.01.010 · Cited by 73
Norden, D. M., Trojanowski, P. J., Walker, F. R., & Godbout, J. P. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.014 · Cited by 73
Cited by
Current Strategies for Brain Drug Delivery
Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954
“The results showed that IGF-1 genes assisted the recovery of stroke-induced damage including BBB permeability and neuroinflammation [99].”
BackgroundImmune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy?
Qiu, Y.-M., Zhang, C.-L., Chen, A.-Q., Wang, H.-L., Zhou, Y.-F., Li, Y.-N., & Hu, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.678744 · Cited by 399
Michinaga, S., & Koyama, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030571 · Cited by 263
Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
Bhalla, S., Mehan, S., Khan, A., & Rehman, M. U. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104896 · Cited by 108
Metadata
- Authors
- Okoreeh, A. K., Bake, S., & Sohrabji, F.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2017-03-20
- Volume
- 65
- Issue
- 7
- Pages
- 1043-1058
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2600724118
- Cited by
- 55
- References
- 10
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.